QPPV.COM KNOWLEDGE ASSESSMENT

Knowledge Assessment: GVP Module VI, Patient Support Programmes and Solicited Reports

Test your understanding of the concepts covered by GVP Module VI: Patient Support Programmes and Solicited Reports.

Question 1 of 10Pass mark: 80%

Question 1 of 10 Why should a PSP avoid relying on individual programme personnel to decide informally whether information is important enough to reach pharmacovigilance?

Because programme personnel are prohibited from recording safety information Because informal decisions create a risk of inconsistent recognition, delayed escalation, and loss of potentially reportable information Because only the QPPV may communicate with patients Because every programme interaction must be conducted by a regulator

Question 2 of 10 Which sequence best reflects the appropriate pharmacovigilance assessment of information received through a patient support programme?

Identify the programme as a PSP, automatically create an ICSR, and submit every event Determine whether collection was organised or solicited, assess the safety information, evaluate ICSR validity, and apply the appropriate reporting pathway Treat the information as spontaneous unless it was collected by a healthcare professional Wait for the programme vendor to determine whether the information is reportable before involving pharmacovigilance

Question 3 of 10 A PSP vendor receives information suggesting a serious adverse reaction. Which control is most important at the point of receipt?

A defined escalation route and timeline to the responsible MAH pharmacovigilance function Waiting until the next scheduled monthly vendor meeting Allowing the vendor to close the record if the patient is recovering Submitting the information directly to authorities without MAH assessment

Question 4 of 10 Who retains overall responsibility for appropriate management and submission of valid safety reports arising from an MAH's PSP when operational activities are outsourced?

The patient enrolled in the programme The third-party vendor alone The MAH, supported by documented oversight and defined vendor responsibilities The national competent authority receiving the report

Question 5 of 10 Which governance arrangement is most consistent with the article's expectations for an MAH using a PSP vendor?

The vendor independently decides which reports require submission, with no MAH review The MAH defines contractual responsibilities, escalation and transfer timelines, follow-up, quality requirements, reconciliation, training, and oversight The MAH transfers all responsibility to the vendor once the contract is signed The vendor sends only serious cases because non-serious information is outside the MAH's responsibility

Question 6 of 10 Why is it professionally important to distinguish a PSP from other organised data collection systems?

Because only PSPs can collect safety information after authorisation Because the nature and classification of the source influence how resulting reports are assessed and managed Because information from all other organised systems must be ignored unless published Because classification determines that every collected event is serious

Question 7 of 10 Which factor is least appropriate as the sole basis for deciding whether a programme is a PSP under the revised framework?

Whether the MAH initiated the programme Whether patients enrol to support product use or management of their condition Whether two-way communication exists with patients or healthcare professionals Whether the organisation has historically used the label 'PSP' for the programme

Question 8 of 10 A programme originally focused on adherence support is expanded to include structured questioning about adverse effects. What should the MAH do?

Retain the original classification because the programme name has not changed Reassess the programme's regulatory characteristics and update PV controls where necessary Assume that all information collected before the change is invalid Terminate the programme because adherence services cannot collect safety information

Question 9 of 10 Which statement best describes the relationship between an adverse event and an adverse reaction in PSP processing?

They are interchangeable terms whenever information is collected by a PSP An adverse event is any reported outcome, whereas an adverse reaction involves suspicion of a causal relationship requiring regulatory assessment An adverse reaction can only be reported by a healthcare professional An adverse event becomes an adverse reaction only if it is serious

Question 10 of 10 A patient already has an ICSR in the MAH database. A later PSP interaction provides the outcome and additional clinical details. What should normally occur?

Create a new independent case because the source is a PSP Treat the information as potential follow-up to the existing case and reconcile it with that record Discard the information because the original case has already been submitted Classify the interaction as a duplicate only if the same reporter was involved

Knowledge Assessment: GVP Module VI, Patient Support Programmes and Solicited Reports

Cookie Settings